AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2004
May 21, 2004
30786_dirs_2004-05-21_8ba49c4f-0c51-4532-a3b5-b14d01b5cba1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO)
CIK: 0000012208
Period of Report: 2004-02-04
Reporting Person: SCHWARTZ NORMAN D (Director, President, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2004-02-04 | Incentive Stock Option | $58.85 | A | 3737 | Acquired | 2014-02-04 | Class B Common Stock (3737) | Direct |
| 2004-02-04 | Non Qualified Stock Option | $53.5 | A | 60553 | Acquired | 2014-02-04 | Class B Common Stock (60553) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class B Common Stock | 15750 | Direct |
| Class B Common Stock | 9870 | Indirect |
| Class A Common Stock | 211454 | Direct |
| Class B Common Stock | 528480 | Indirect |
| Class B Common Stock | 13726 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Incentive Stock Option | $31.77 | 2012-02-06 | Class B Common Stock (7928) | 7928 | Direct |
| Non Qualified Stock Option | $28.88 | 2012-02-06 | Class B Common Stock (2072) | 2072 | Direct |
| Incentive Stock Option | $39.6 | 2013-02-05 | Class B Common Stock (2955) | 2955 | Direct |
| Non Qualified Stock Option | $36 | 2013-02-05 | Class B Common Stock (64828) | 64828 | Direct |
| Incentive Stock Option | $12.44 | 2010-02-02 | Class B Common Stock (7500) | 7500 | Direct |
| Incentive Stock Option | $13.14 | 2010-09-19 | Class B Common Stock (12010) | 12010 | Direct |
| Non Qualified Stock Option | $11.94 | 2010-09-19 | Class B Common Stock (5490) | 5490 | Direct |
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13